Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

Código QR

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers

PurposePatients with advanced/relapsed rare cancers have few treatment options. Analysis of circulating tumor DNA in plasma may identify actionable genomic biomarkers using a non-invasive approach.Patients and MethodsRare cancer patients underwent prospective plasma-based NGS testing. Tissue NGS to...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Hitomi Sumiyoshi Okuma, Kan Yonemori, Yuki Kojima, Maki Tanioka, Kazuki Sudo, Emi Noguchi, Susumu Hijioka, Keiko Wakakuwa, Ken Kato, Akihiro Hirakawa, Aya Kuchiba, Takashi Kubo, Hitoshi Ichikawa, Akihiko Yoshida, Yasushi Yatabe, Kenichi Nakamura, Hiroyuki Mano, Noboru Yamamoto, Yasuhiro Fujiwara
Formato:	article
Lenguaje:	EN
Publicado:	Frontiers Media S.A. 2021
Materias:	rare cancer CtDNA (circulating tumor DNA) precision medicine soft tissue sarcoma targeted therapy Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Acceso en línea:	https://doaj.org/article/35ecf0472ced44858aa96591a8e7fa2a
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review
por: Maisam Makarem, et al.
Publicado: (2021)

Liquid Biopsy to Detect Minimal Residual Disease: Methodology and Impact
por: Natasha Honoré, et al.
Publicado: (2021)

Validation of liquid biopsy: plasma cell-free DNA testing in clinical management of advanced non-small cell lung cancer
por: Veldore VH, et al.
Publicado: (2018)

Rational Development of Liquid Biopsy Analysis in Renal Cell Carcinoma
por: Kate I. Glennon, et al.
Publicado: (2021)

Cis-oriented solvent-front EGFR G796S mutation in tissue and ctDNA in a patient progressing on osimertinib: a case report and review of the literature
por: Klempner SJ, et al.
Publicado: (2017)

BRCA1 promoter hypermethylation on circulating tumor DNA correlates with improved survival of patients with ovarian cancer
por: Maha Elazezy, et al.
Publicado: (2021)

Advantages and Challenges of Using ctDNA NGS to Assess the Presence of Minimal Residual Disease (MRD) in Solid Tumors
por: Lionel Larribère, et al.
Publicado: (2021)

Homologous Recombination Repair Gene Mutation Characterization by Liquid Biopsy: A Phase II Trial of Olaparib and Abiraterone in Metastatic Castrate-Resistant Prostate Cancer
por: T. Hedley Carr, et al.
Publicado: (2021)

Case Report: The Added Value of Liquid Biopsy in Advanced Colorectal Cancer From Clinical Case Experiences
por: Paola Ulivi, et al.
Publicado: (2021)

Liquid biopsy for cancer management: a revolutionary but still limited new tool for precision medicine
por: Arechederra María, et al.
Publicado: (2020)

Gene Mutations in Circulating Tumour DNA as a Diagnostic and Prognostic Marker in Head and Neck Cancer—A Systematic Review
por: Markéta Hudečková, et al.
Publicado: (2021)

Biological Adaptations of Tumor Cells to Radiation Therapy
por: Angeles Carlos-Reyes, et al.
Publicado: (2021)

Expressão de Genes relacionados às Vias de Reparo de Danos em Fita Dupla no DNA em Pacientes com Síndrome Mielodisplásica
por: Howard Lopes Ribeiro Junior, et al.
Publicado: (2016)

Metilação de DNA e Câncer
por: Naila Francis Paulo de Oliveira, et al.
Publicado: (2010)

KRAS and NRAS genes mutations as biomarkers in the therapy of colorectal cancer and the basic methods of their detection
por: Olga I. Brovkina, et al.
Publicado: (2021)

Mycelial DNA persistence in a forest soil
por: Matthew Gordon, et al.
Publicado: (2021)

SYNTHESIS, CHARACTERIZATION, LUMINESCENCE AND DNA BINDING PROPERTIES OF Ln (III)-SCHIFF BASE FAMILY
por: SAGAR BABU,S. VIDYA, et al.
Publicado: (2017)

Circulating Tumor DNA as a Predictive Marker of Recurrence for Patients With Stage II-III Breast Cancer Treated With Neoadjuvant Therapy
por: Po-Han Lin, et al.
Publicado: (2021)

Circulating Tumor DNA and Minimal Residual Disease (MRD) in Solid Tumors: Current Horizons and Future Perspectives
por: Yan Peng, et al.
Publicado: (2021)

Diagnostic Accuracy of Liquid Biopsy in Endometrial Cancer
por: Marta Łukasiewicz, et al.
Publicado: (2021)

X-ray repair cross-complementing protein 1 (XRCC1) loss promotes β-lapachone –induced apoptosis in pancreatic cancer cells
por: Yansong Zheng, et al.
Publicado: (2021)

Liquid Biopsies beyond Mutation Calling: Genomic and Epigenomic Features of Cell-Free DNA in Cancer
por: Arlou Kristina Angeles, et al.
Publicado: (2021)

Meta-analysis of the studies dedicated to the predictive significance of circulating tumor DNA in pancreatic cancer
por: A. S. Popova, et al.
Publicado: (2020)

Adjuvant targeted therapy for non-small cell lung cancer
por: Konstantin K. Laktionov, et al.
Publicado: (2020)

Uptake of DNA by cancer cells without a transfection reagent
por: Kong,Yanping, et al.
Publicado: (2017)

Morphoquantitative Analysis of the Intraepithelial Neoplasic Uterine Cells by Computer Image System
por: Lima,Jacqueline Silva Brito, et al.
Publicado: (2008)

Epigenetic activation of the elongator complex sensitizes gallbladder cancer to gemcitabine therapy
por: Sunwang Xu, et al.
Publicado: (2021)

Molecular-Genetic Aspects of Breast Cancer
por: Krasteva M., et al.
Publicado: (2014)

Liquid biopsy identifies actionable dynamic predictors of resistance to Trastuzumab Emtansine (T-DM1) in advanced HER2-positive breast cancer
por: Matteo Allegretti, et al.
Publicado: (2021)

Redefine Hyperprogressive Disease During Treatment With Immune-Checkpoint Inhibitors in Patients With Gastrointestinal Cancer
por: Zhenghang Wang, et al.
Publicado: (2021)

Cancer-associated fibroblast heterogeneity is associated with organ-specific metastasis in pancreatic ductal adenocarcinoma
por: Xingyi Pan, et al.
Publicado: (2021)

Head and Neck Cancers Are Not Alike When Tarred with the Same Brush: An Epigenetic Perspective from the Cancerization Field to Prognosis
por: Diego Camuzi, et al.
Publicado: (2021)

Opposite effects of the triple target (DNA-PK/PI3K/mTOR) inhibitor PI-103 on the radiation sensitivity of glioblastoma cell lines proficient and deficient in DNA-PKcs
por: Cholpon S. Djuzenova, et al.
Publicado: (2021)

Cyclin E1 in Murine and Human Liver Cancer: A Promising Target for Therapeutic Intervention during Tumour Progression
por: Roland Sonntag, et al.
Publicado: (2021)

Combined multimodal ctDNA analysis and radiological imaging for tumor surveillance in Non-small cell lung cancer
por: Martin Metzenmacher, et al.
Publicado: (2022)

The natural sulfoglycolipid derivative SQAP improves the therapeutic efficacy of tissue factor-targeted radioimmunotherapy in the stroma-rich pancreatic cancer model BxPC-3
por: Yoichi Takakusagi, et al.
Publicado: (2022)

The Help of HPV Integration Testing to Avoid the Misdiagnosis of a Patient with Stage Ia1 Cervical Cancer: A Case Report and Literature Review
por: Li J, et al.
Publicado: (2021)

Identification of a Chemotherapeutic Lead Molecule for the Potential Disruption of the FAM72A-UNG2 Interaction to Interfere with Genome Stability, Centromere Formation, and Genome Editing
por: Senthil Renganathan, et al.
Publicado: (2021)

An Abnormal Host/Microbiomes Signature of Plasma-Derived Extracellular Vesicles Is Associated to Polycythemia Vera
por: Monica Barone, et al.
Publicado: (2021)

Rare tumors